Plasmapp Co., Ltd. (KOSDAQ:405000)
South Korea · Delayed Price · Currency is KRW 3,500.00
-30.00 (-0.85%)
At close: Sep 4, 2026
Plasmapp Market Cap
Plasmapp has a market cap or net worth of 13.43 billion as of September 4, 2026. Its market cap has decreased by -55.41% in one year.
Market Cap
13.43B
Enterprise Value
23.88B
Revenue
12.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,500.00
ChartMarket Cap Chart
Since October 21, 2022, Plasmapp's market cap has decreased from 118.64B to 13.43B, a decrease of -88.68%. That is a compound annual growth rate of -43.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 13.43B | -39.66% |
| Dec 30, 2025 | 22.25B | -35.54% |
| Dec 30, 2024 | 34.53B | -56.62% |
| Dec 28, 2023 | 79.58B | -21.19% |
| Dec 29, 2022 | 100.99B | -14.88% |
| Oct 21, 2022 | 118.64B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 180.20B |
| CG MedTech | 120.30B |
| Sewoon Medical | 104.18B |
| OSTEONIC | 83.86B |
| SCL Science | 76.02B |
| KM Corporation | 41.87B |
| Wonbiogen | 41.31B |
| MEDYSSEY Co.,Ltd | 37.70B |